Page last updated: 2024-08-26

norcantharidin and tamoxifen

norcantharidin has been researched along with tamoxifen in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, A; Cui, J; Jiang, Y; Li, L; Lian, L; Liu, Q; Qi, B; Qian, K; Qiu, Z; Zhang, B; Zhang, P; Zhang, X	1

Other Studies

1 other study(ies) available for norcantharidin and tamoxifen

Article	Year
Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells. PloS one, 2019, Volume: 14, Issue:5 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cyclin-Dependent Kinase 3; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; MicroRNAs; Signal Transduction; Tamoxifen; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2019

Article

Year

Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.

PloS one, 2019, Volume: 14, Issue:5

Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cyclin-Dependent Kinase 3; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; MicroRNAs; Signal Transduction; Tamoxifen; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019